Safety, Tolerability, and Pharmacokinetics of SPL84 in Healthy Volunteers
Clinical trial NCT06217952 · COMPLETED
Trial details
- NCT number
- NCT06217952
- Sponsor
- SpliSense Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-05
- Primary completion
- 2023-08-06
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.